ストックスクリーナーアプリを入手
1.02
0.00%
0.00
アフターアワーズ：
1.02
前日終値:
$1.02
開ける：
$1.02
24時間の取引高:
428.57K
Relative Volume:
0.49
時価総額：
$87.66M
収益：
-
当期純損益:
$-21.65M
株価収益率:
-3.0714
EPS:
-0.3321
ネットキャッシュフロー:
$-15.84M
1週間 パフォーマンス:
-9.73%
1か月 パフォーマンス:
-3.77%
6か月 パフォーマンス:
-5.12%
1年 パフォーマンス:
-50.72%
1日の値動き範囲:
$0.9754
$1.02
1週間の範囲:
$0.9754
$1.155
52週間の値動き範囲:
$0.7709
$2.14
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
CRDL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
1.02 | 97.06M | 0 | -21.65M | -15.84M | -0.3321 |
|
ZTS
Zoetis Inc
|
120.24 | 52.69B | 9.40B | 2.65B | 2.22B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.66 | 43.09B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.46 | 41.90B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
23.97 | 28.06B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
448.91 | 19.55B | 3.08B | 1.24B | 1.07B | 25.61 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-02 | 開始されました | H.C. Wainwright | Buy |
| 2025-01-28 | 開始されました | Rodman & Renshaw | Buy |
| 2024-06-26 | 開始されました | ROTH MKM | Buy |
| 2024-04-22 | 開始されました | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc (CRDL) 最新ニュース
Can technical indicators confirm Cardiol Therapeutics Inc.’s reversalGDP Growth & Pattern Based Trade Signal System - newser.com
Cardiol Therapeutics Inc. stock chart pattern explainedSell Signal & High Return Stock Watch Alerts - newser.com
Is it time to cut losses on Cardiol Therapeutics Inc.Stop Loss & Verified Short-Term Trading Plans - newser.com
Pattern recognition hints at Cardiol Therapeutics Inc. upsideJuly 2025 Rallies & AI Powered Market Entry Strategies - newser.com
Historical volatility pattern of Cardiol Therapeutics Inc. visualizedWeekly Market Outlook & Precise Swing Trade Alerts - newser.com
What insider purchases suggest about Cardiol Therapeutics Inc. (CT9) stockJuly 2025 News Drivers & Stock Market Timing Techniques - newser.com
Is this a good reentry point in Cardiol Therapeutics Inc.CEO Change & Weekly Momentum Picks - newser.com
Key metrics from Cardiol Therapeutics Inc.’s quarterly data2025 Investor Takeaways & Short-Term Trading Alerts - newser.com
Is Cardiol Therapeutics Inc. stock dividend yield sustainableTrend Reversal & Stepwise Swing Trade Plans - newser.com
Will Cardiol Therapeutics Inc. (CT9) stock recover faster than industryShare Buyback & Daily Volume Surge Trade Alerts - newser.com
Will earnings trigger a reversal in Cardiol Therapeutics Inc.2025 Trade Ideas & Verified Short-Term Plans - newser.com
Is Cardiol Therapeutics Inc. (CT9) stock undervalued at current price2025 Big Picture & Verified Entry Point Signals - newser.com
How Cardiol Therapeutics Inc. stock benefits from tech adoption2025 Technical Patterns & Fast Entry Momentum Alerts - newser.com
Technical analysis overview for Cardiol Therapeutics Inc. stockJuly 2025 Weekly Recap & High Accuracy Investment Signals - newser.com
Is Cardiol Therapeutics Inc. stock cheap at current valuation2025 Performance Recap & Free Community Consensus Stock Picks - fcp.pa.gov.br
Why Cardiol Therapeutics Inc. (CT9) stock attracts HNW investorsJuly 2025 Reactions & Reliable Volume Spike Alerts - fcp.pa.gov.br
What market sentiment indicators show for Cardiol Therapeutics Inc. (CT9) stock2025 Top Gainers & Capital Efficient Trade Techniques - newser.com
Can Cardiol Therapeutics Inc. (CT9) stock deliver strong annual returnsEarnings Overview Summary & Stock Portfolio Risk Management - newser.com
Using Python tools to backtest Cardiol Therapeutics Inc. strategiesDividend Hike & Weekly Momentum Picks - newser.com
Trading (CRDL) With Integrated Risk Controls (CRDL:CA) - news.stocktradersdaily.com
Advanced analytics toolkit walkthrough for Cardiol Therapeutics Inc.Market Risk Report & Capital Efficiency Focused Ideas - newser.com
Cardiol Therapeutics files for mixed shelf of up to $150 million - MarketScreener
[F-10] Cardiol Therapeutics Inc. SEC Filing - Stock Titan
Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases - Investing News Network
Cardiol Therapeutics to Present Promising ARCHER Trial Results at ESC Meeting - TipRanks
[6-K] Cardiol Therapeutics Inc. Current Report (Foreign Issuer) | CRDL SEC FilingForm 6-K - Stock Titan
Full technical analysis of Cardiol Therapeutics Inc. stock2025 Market Trends & Long Hold Capital Preservation Plans - newser.com
Why Cardiol Therapeutics Inc. stock is seen as undervalued2025 Breakouts & Breakdowns & Risk Managed Investment Entry Signals - newser.com
How Cardiol Therapeutics Inc. stock responds to policy changesBull Run & Weekly High Momentum Picks - newser.com
How to build a custom watchlist for Cardiol Therapeutics Inc.July 2025 Sector Moves & Short-Term High Return Ideas - newser.com
Real time social sentiment graph for Cardiol Therapeutics Inc.2025 Geopolitical Influence & Stepwise Swing Trade Plans - newser.com
How Cardiol Therapeutics Inc. stock reacts to bond yieldsProfit Target & Free Growth Oriented Trading Recommendations - newser.com
Top chart patterns to watch in Cardiol Therapeutics Inc.2025 Buyback Activity & Daily Profit Focused Screening - newser.com
Will Cardiol Therapeutics Inc. (CT9) stock see valuation expansionTrade Exit Summary & Weekly Stock Breakout Alerts - newser.com
Is Cardiol Therapeutics Inc. stock poised for growthBear Alert & Risk Controlled Daily Plans - newser.com
Cardiol Therapeutics Inc (CRDL) 財務データ
収益
当期純利益
現金流量
EPS
1.18%
0.10%
大文字化:
|
ボリューム (24 時間):